Start Your Journey To Wealth

It takes just a few minutes to register.

Your Money - Best Investment ISA - Large Portfolio 2024
Boring money - Best for Customer Service 2022
Broker Chooser - Best broker for funds 2022

HALEON PLC ORD GBP0.01

Symbol: HLN

This security went ex-dividend on 24/04/2025. Pay date is 05/06/2025

Streaming is not available when market closed. Some prices may be as at close of business from the previous working day.

Whilst we endeavour to price investments on a real-time streaming or 15 min delayed basis, some prices may be as at close of business from the previous working day.

Invest in this share within an ISA, JISA, SIPP or Investment Account

Login Open an account

Overview

Core Data
Latest Dividend Information

Ex-Dividend Date 24 Apr 2025
Pay Date 5 Jun 2025
Total Dividends - Year to Date6.6
Dividend Yield (%)1.698

Historical Data & Ratios

Avg Volume Over 10 Days25.1727
Market Cap (M)34051.9400
Price/Earnings (PE)24.6481
Earnings Per Share15.77
Revenue Per Share1.2243
Return on Equity %8.8002

1 Month Performance Chart

One Month Chart

Cost and Charges Information

This calculator provides you with costs and charges information regarding our charges and, where relevant, the costs within this investment product

Account Type

  • Investment Account
  • Stocks & Shares ISA
  • SIPP

Annual charges

These are the annual costs based on an initial investment amount of over 1 year assuming a net zero growth rate

Cost Category % of Investment lump sum costs
Our annual fee

Our annual fee

Includes our platform fee at 0.30% per annum (excluding Charles Stanley Multi Asset Funds and anycash held). The min fee is £60, the max is £600 per annum, plus SIPP administration fee (if applicable, only charged if < £30,000 held) – see here 		0.30%
Dealing charges

Dealing charges

Any one-off commission charges associated with investing. Note that government taxes and levies are not included. This does not include any commission credits you may have available 		N/A
Product provider costs

Product provider costs

Product provider costs shown are inclusive of the fund ongoing charges figure (OCF), transaction costs and incidental costs 		N/A N/A
Total (£)

Total (£)

Costs per annum displayed in monetary value
Total (%)

Total (%)

Costs per annum displayed as a percentage of investment value

Cumulative effect of charges on your investment's return

This illustration assumes that costs occur evenly throughout the year, charges are paid out of the investment evenly throughout the year, and that an annual growth rate of applies evenly throughout the year, before any charges including product charges

lump sum invested with an assumed growth rate of 1 year years
What you might get back at  with no charges applied

What you might get back at  with no charges applied

These are the illustrative values of a  investment after growth and no costs applied at the end of the defined period
Annual charges

Annual charges

These are the annual costs based on an initial investment amount of assuming a net zero growth rate
Effect of charges on return (%)

Effect of charges on return (%)

These are the overall costs in percentage terms, based on an initial investment amount of assuming a growth rate
Effect of charges on return (£)

Effect of charges on return (£)

These are the overall costs in monetary value, based on an initial investment amount of assuming a growth rate
What you might get back at with charges applied

What you might get back at with charges applied

These are the illustrative values of a investment after growth and costs at the end of the defined period

This illustration is not a forecast of future investment performance but merely a means to demonstrate the potential impact of costs and charges for an assumed return of . Whilst we make reasonable endeavours to ensure the accuracy of third party charges information, this is intended for illustrative purposes only and should not be relied upon. We do not warrant or represent that this information is accurate, complete or up to date, therefore we accept no responsibility or liability for its use

Charts

  • Chart Options

    Select Timeframe Add a sector as a comparator Add an index as a comparator Add a share as a comparator

      Add a moving average as a comparator Add a lower indicator as a comparator Chart Style Current Comparators

      Company

      Business Summary

      Haleon plc is a consumer healthcare company. The Company's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.

      Financial Summary

      BRIEF: For the fiscal year ended 31 December 2024, Haleon PLC revenues decreased 1% to £11.23B. Net income increased 37% to £1.44B. Revenues reflect North America segment decrease of 4% to £4.04B, APAC segment remaining flat at £2.56B, US & Puerto Rico segment decrease of 4% to £3.62B. Net income reflects EMEA and LatAm segment income increase of 4% to £1.05B, Corporate and other unallocated segment loss decrease of 15% to £93M.

      Financials


      Income Statement - All values are in GBP (M).

      Year Ending

      31/12/2024

      31/12/2023

      31/12/2022

      31/03/2022

      Total Revenue 11,233.00 11,302.00 10,858.00 9,545.00
      Gross profit 7,134.00 6,962.00 6,725.00 5,984.00
      Operating Profit/Loss 2,193.00 2,107.00 1,617.00 1,673.00
      Profit Before Tax 1,910.00 1,628.00 1,618.00 1,636.00
      Profit After Tax 1,475.00 1,111.00 1,119.00 1,439.00
      Equity Holders of Parent Company 1,442.00 1,049.00 1,060.00 1,390.00
      Minority Interest 25.00 61.00 67.00 76.00


      Balance Sheet - All values are in GBP (M).

      Year Ending

      31/12/2024

      31/12/2023

      31/12/2022

      31/03/2022

      Total Non-Current Assets 28,597.00 29,237.00 30,756.00 29,200.00
      Total Current Assets 5,718.00 4,818.00 4,059.00 5,251.00
      Total Assets 34,315.00 34,055.00 34,815.00 34,451.00
      Total Liabilities 18,091.00 17,326.00 18,358.00 7,971.00
      Total Net Assets 16,224.00 16,729.00 16,457.00 26,480.00
      Shareholders Funds 16,166.00 16,606.00 16,331.00 26,355.00
      Minority Interests 25.00 61.00 67.00 76.00
      Total Equity 16,224.00 16,729.00 16,457.00 26,480.00

      Outlook

      Upgrades & Downgrades (Latest)

      DateBrokerRecommendationPriceOld TargetNew TargetChange
      28th Feb 2025Berenberg BankReiteration398p456p457pBuy
      5th Aug 2024Berenberg BankReiteration369p410p447pBuy
      18th Apr 2024HSBCNew Coverage321p0p0pBuy
      9th Apr 2024BarclaysReiteration322p390p383pOverweight
      6th Nov 2023BarclaysReiteration323p367p391pOverweight
      10th Oct 2023JP Morgan CazenoveReiteration340p0p280pUnderweight

      Time & Sales

      All prices are in GBX and times are in GMT. Last 20 trades shown. Trade type is estimated and should be treated as indicative only.

      Date Time Price Volume Type
      2 May 2025 16:48 398.4 731 Buy
      2 May 2025 16:41 404.23 79,766 Buy
      2 May 2025 16:35 398.4 85,503 Sell
      2 May 2025 16:35 398.4 115,646 Sell
      2 May 2025 16:35 398.4 50,235 Sell
      2 May 2025 16:35 398.4 7,657,751 Sell
      2 May 2025 16:35 398.4 82 Sell
      2 May 2025 16:35 398.4 612 Sell
      2 May 2025 16:35 398.4 345 Sell
      2 May 2025 16:35 398.4 2,595 Sell
      2 May 2025 16:35 398.4 80,271 Sell
      2 May 2025 16:29 398.7 709 Unknown
      2 May 2025 16:29 398.7 1,256 Unknown
      2 May 2025 16:29 398.6 849 Sell
      2 May 2025 16:29 398.6 615 Sell
      2 May 2025 16:29 398.6 567 Sell
      2 May 2025 16:29 398.6 519 Sell
      2 May 2025 16:29 398.6 23 Sell
      2 May 2025 16:29 398.6 2,120 Sell
      2 May 2025 16:29 398.6 1,766 Sell

      Selected data supplied by Thomson Reuters ©  View restrictions.

      VIEW ALL MARKET NEWS

      Investment involves risk. You may get back less than invested.